105 related articles for article (PubMed ID: 10801253)
1. Effect of fluvastatin on proteinuria in patients with immunoglobulin A nephropathy.
Buemi M; Allegra A; Corica F; Aloisi C; Giacobbe M; Pettinato G; Corsonello A; Senatore M; Frisina N
Clin Pharmacol Ther; 2000 Apr; 67(4):427-31. PubMed ID: 10801253
[TBL] [Abstract][Full Text] [Related]
2. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
3. No detrimental effect on renal function during long-term use of fluvastatin in renal transplant recipients in the Assessment of Lescol in Renal Transplantation (ALERT) study.
Fellström B; Abedini S; Holdaas H; Jardine AG; Staffler B; Gimpelewicz C;
Clin Transplant; 2006; 20(6):732-9. PubMed ID: 17100723
[TBL] [Abstract][Full Text] [Related]
4. Effect of fluvastatin and dipyridamole on proteinuria and renal function in childhood IgA nephropathy with mild histological findings and moderate proteinuria.
Kano K; Nishikura K; Yamada Y; Arisaka O
Clin Nephrol; 2003 Aug; 60(2):85-9. PubMed ID: 12940609
[TBL] [Abstract][Full Text] [Related]
5. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
[TBL] [Abstract][Full Text] [Related]
6. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
Rostoker G; Ben Maadi A; Remy P; Lang P; Lagrue G; Weil B
Nephrol Dial Transplant; 1995; 10(1):25-9. PubMed ID: 7724024
[TBL] [Abstract][Full Text] [Related]
7. Long-term fluvastatin reduces the hazardous effect of renal impairment on four-year atherosclerotic outcomes (a LIPS substudy).
Lemos PA; Serruys PW; de Feyter P; Mercado NF; Goedhart D; Saia F; Arampatzis CA; Soares PR; Ciccone M; Arquati M; Cortellaro M; Rutsch W; Legrand V
Am J Cardiol; 2005 Feb; 95(4):445-51. PubMed ID: 15695126
[TBL] [Abstract][Full Text] [Related]
8. Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.
Szeto CC; Chow KM; Kwan BC; Chung KY; Leung CB; Li PK
Am J Kidney Dis; 2008 May; 51(5):724-31. PubMed ID: 18436082
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of statins on arterial pressure and stiffness of hypertensives.
Ichihara A; Hayashi M; Koura Y; Tada Y; Kaneshiro Y; Saruta T
J Hum Hypertens; 2005 Feb; 19(2):103-9. PubMed ID: 15361892
[TBL] [Abstract][Full Text] [Related]
11. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
[TBL] [Abstract][Full Text] [Related]
12. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
[TBL] [Abstract][Full Text] [Related]
13. Development and pharmacology of fluvastatin.
Jokubaitis LA
Br J Clin Pract Suppl; 1994 Dec; (77):11-5. PubMed ID: 19489169
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
[TBL] [Abstract][Full Text] [Related]
15. No effect of fluvastatin on the bone mineral density of children with minimal change glomerulonephritis and some focal mesangial cell proliferation, other than an ameliorating effect on their proteinuria.
Kano K; Nishikura K; Yamada Y; Arisaka O
Clin Nephrol; 2005 Feb; 63(2):74-9. PubMed ID: 15730048
[TBL] [Abstract][Full Text] [Related]
16. Effects of a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, fluvastatin, on coronary spasm after withdrawal of calcium-channel blockers.
Yasue H; Mizuno Y; Harada E; Itoh T; Nakagawa H; Nakayama M; Ogawa H; Tayama S; Honda T; Hokimoto S; Ohshima S; Hokamura Y; Kugiyama K; Horie M; Yoshimura M; Harada M; Uemura S; Saito Y;
J Am Coll Cardiol; 2008 May; 51(18):1742-8. PubMed ID: 18452779
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone breakthrough during therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in proteinuric patients with immunoglobulin A nephropathy.
Horita Y; Taura K; Taguchi T; Furusu A; Kohno S
Nephrology (Carlton); 2006 Oct; 11(5):462-6. PubMed ID: 17014562
[TBL] [Abstract][Full Text] [Related]
18. Statins stabilize the renal function of IgA nephropathy.
Moriyama T; Oshima Y; Tanaka K; Iwasaki C; Ochi A; Itabashi M; Takei T; Uchida K; Nitta K
Ren Fail; 2014 Apr; 36(3):356-60. PubMed ID: 24341619
[TBL] [Abstract][Full Text] [Related]
19. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
[TBL] [Abstract][Full Text] [Related]
20. Effects of D-003, a mixture of long-chain aliphatic primary acids, fluvastatin and the combined therapy of D-003 plus fluvastatin on the lipid profile of normocholesterolemic rabbits.
Mendoza S; Gamez R; Mas R; Goicochea E
Int J Tissue React; 2003; 25(3):81-9. PubMed ID: 14756189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]